A Safety, Tolerability and Pharmacokinetic Study of CPP-115

Clinical trial NCT01493596 · COMPLETED

Trial details

NCT number: NCT01493596
Sponsor: Catalyst Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cocaine Dependency

Start date: 2011-12-01
Primary completion: 2012-06-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.